Whereas hosts receiving either no ACT or control ACT succumbed to OVA-T4–bearing tumors within 12 days after challenge, mice (n = 7) receiving Ptpn22–/– memory phenotype cells remained entirely tumor free for at least 90 days following tumor cell injection (Figure 6D). Here, PTPN22 is linked to neoplasm.